Table 1 Site characteristics
Site ID | Site Location | Funding Type | No. of patients seen per 3-month period | No, of departments Included | Treatment modality departments Included | Tumour Streams Included | No. of streams included | FTE Psycho-social staff |
|---|---|---|---|---|---|---|---|---|
1 | Major city | Public | ≥100 | 3 | Med Oncology Rad Oncology Haematology | All | ≥3 | 0.8 |
2 | Inner regional | Public | < 100 | 3 | Med Oncology Rad Oncology Haematology | All | ≥3 | 0.6 |
3 | Inner regional | Public | < 100 | 1 | Med Oncology | All | ≥3 | 0.6 |
4 | Major city | Public | ≥100 | 2 | Med Oncology Surgical | Gastro -intestinal | 1 | 2.4 |
5 | Inner regional | Public | < 100 | 3 | Med Oncology Rad Oncology Haematology | All | ≥3 | 0 |
6 | Major city | Public | ≥100 | 2 | Med oncology Haematology | All | ≥3 | 7.9 |
7 | Major city | Public | ≥100 | 1 | Surgical | Upper GI | 1 | 2.4 |
8 | Major city | Public | < 100 | 3 | Med Oncology Rad Oncology Haematology | All | ≥3 | 5 |
9 | Major city | Public | ≥100 | 1 | Haematology | Lymphoma, acute leukemia, multiple myeloma | ≥3 | 2.4 |
10 | Major city | Public | ≥100 | 3 | Med Oncology Rad Oncology Surgical | Head & Neck | 1 | 4 |
11 | Major city | Public and Private | ≥100 | 1 | Med Oncology | Sarcoma, Gynae | 2 | 6.9 |
12 | Major city | Private | ≥100 | 1 | Med Oncology | All | ≥3 | 0.9 |